Sagimet Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and ...

Completed Phase 1 pharmacokinetic (PK) clinical trial of denifanstat and resmetirom combination Phase 2 trial of ...

Sagimet Biosciences Inc. (SGMT) Presents at Oppenheimer 36th Annual Healthcare Life ...

Oppenheimer 36th Annual Healthcare Life Sciences Conference February 26, 2026 9:20 AM ESTCompany ParticipantsDavid Happel ...